The Isolation of New Pore-Forming Toxins from the Sea Anemone Provides Insights into the Mechanisms of Actinoporin Evolution
Overview
Authors
Affiliations
Random mutations and selective pressure drive protein adaptation to the changing demands of the environment. As a consequence, nature favors the evolution of protein diversity. A group of proteins subject to exceptional environmental stress and known for their widespread diversity are the pore-forming hemolytic proteins from sea anemones, known as actinoporins. In this study, we identified and isolated new isoforms of actinoporins from the sea anemone (fragaceatoxins). We characterized their hemolytic activity, examined their stability and structure, and performed a comparative analysis of their primary sequence. Sequence alignment reveals that most of the variability among actinoporins is associated with non-functional residues. The differences in the thermal behavior among fragaceatoxins suggest that these variability sites contribute to changes in protein stability. In addition, the protein-protein interaction region showed a very high degree of identity (92%) within fragaceatoxins, but only 25% among all actinoporins examined, suggesting some degree of specificity at the species level. Our findings support the mechanism of evolutionary adaptation in actinoporins and reflect common pathways conducive to protein variability.
Barroso R, Rodrigues T, Campos A, Almeida D, Guardiola F, Turkina M Mar Drugs. 2025; 23(2).
PMID: 39997203 PMC: 11857728. DOI: 10.3390/md23020079.
Gupta L, Molla J, Prabhu A Mol Biotechnol. 2023; 66(6):1327-1356.
PMID: 37294530 DOI: 10.1007/s12033-023-00776-1.
Ahmed A, Dai C, Kuo Y, Sheu J Metabolites. 2023; 13(3).
PMID: 36984832 PMC: 10056678. DOI: 10.3390/metabo13030392.
Sea Anemones, Actinoporins, and Cholesterol.
Palacios-Ortega J, Heras-Marquez D, Amigot-Sanchez R, Garcia-Montoya C, Torrijos C, Laxalde D Int J Mol Sci. 2022; 23(15).
PMID: 35955905 PMC: 9369217. DOI: 10.3390/ijms23158771.
Cytotoxic effect of sea anemone pore-forming toxin on K562 chronic myeloid leukemia cells.
Abdoli V, Sarkhosh-Inanlou R, Delirezh N, Aghazadeh S, Shaykh-Baygloo N, Imani M Vet Res Forum. 2022; 12(4):481-485.
PMID: 35529825 PMC: 9010839. DOI: 10.30466/vrf.2020.115033.2737.